CEO Lynn Stockwell resigns after affiliate fund irregularities; Roger Bendelac appointed CEO

Drugs Made In America Acquisition Corp.

Lynn Stockwell resigned as CEO, Executive Chair, and Board member of DMAA and affiliate, effective Feb 28, 2026.
Resignation followed board request after Sponsor withdrew ~$1.1M from affiliate's account, including ~$566K overpayment and $200K for unrelated expenses; Sponsor cannot repay.
Roger Bendelac appointed as new CEO; has 30+ years in investment banking/corporate advisory; compensation not yet determined.
Board removed Ms. Stockwell from all positions on Feb 28, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.